Pharmacovigilance and Risk Management

Pharmacovigilance and Risk Management comprises set of pharmacovigilance activities and interventions designed to identify, characterise, prevent or minimise risks relating to medicinal and therapeutic products including the assessment of the effectiveness of their clinical interventions and combination therapies. Drug industry need to promote companies in pharmacovigilance practice to use information technology and to review softwares used in pharmacovigilance and clinical trials. Monitoring unlicensed, off labels and orphan drugs is major task in risk management. Many experts from different pharmacovigilance CRO’s pharmacovigilance service providers and industrial delegates are participating in this conference to share their knowledge and discuss about the new updates.

Market Analysis: The global Pharmacovigilance Market is expected to reach USD 10.27 billion by 2025, according to a new report by Grand View Research, Inc. The market is expected to witness growth at 13.1% CAGR owing to Increasing incidence of ADR is key driver for the growth of pharmacovigilance market. As of 2015, the U.S. FDA received approximately 253,017 serious adverse events and 44,693 deaths associated with adverse drug reactions (ADRs). This shows the potential demand for implementing safety and pharmacovigilance services over the forecast period

  • Information technology in pharmacovigilance and promoting companies
  • Review of softwares used in pharmacovigilance and clinical trials
  • Implementation of Risk Minimization Plans
  • Risk communication: Interface between pharmacovigilance, sales and marketing

Related Conference of Pharmacovigilance and Risk Management

January 22-23, 2021

1 st Global Summit on Generic Drugs and Quality Control

Prague, Czech Republic
January 22-23, 2021

1 st World Congress on Rare Diseases & Orphan Drugs

Prague, Czech Republic
February 26-27, 2021

2nd Annual Congress on Antibiotics and Bacterial Infections

Geneva, Switzerland
March 10-11, 2021

6th Pharmaceutical Chemistry Conference

Paris, France
March 16-17, 2021

14th Global Pharmacovigilance And Clinical Trials Summit

Albufeira, Portugal
April 11-12, 2021

2 nd World Pharma Expo

Tokyo, Japan
April 12-13, 2021

2nd International Conference on Biosimilars & Pharmaceuticals

Auckland, Newzealand
April 28-29, 2021

31st Annual European Pharma Congress

London, UK
April 28-29, 2021

14th European Biosimilars Congress

London, UK
May 10-11, 2021

20th Annual Meet on Pharmaceutical Sciences

Yokohama, Japan
May 12-12, 2021

27th Cognitive Neuroscience Congress

London, UK
May 17-18, 2021

8th European Biopharma Congress

Prague, Czech Republic
June 07-08, 2021

2rd European Conference on Pharmacovigilance and Drug Safety

Prague, Czech Republic
July 10-11, 2021

2 nd Pharma Expo China

Tokyo, Japan
July 26-27, 2021

36th World Pharmacology and Therapeutics Forum

Paris, France
August 16-17, 2021

Global summit on Cosmetic & Reconstructive Surgery

Tokyo, Japan
August 16-17, 2021

34rd World Congress on Pharmacology

London, UK
October 05-06, 2021

International Congress on Drug Delivery

Auckland, Newzealand
October 29-30, 2021

14th World Drug Delivery Summit

Vancouver, Canada
October 29-30, 2021

12th Annual Biomarkers and Clinical Research Congress

Vancouver, Canada
November 16-17, 2021

World Congress on Biologics and Biosimilars

Osaka, Japan
December 02-03, 2021

2nd International conference on Pharma Industry & pharmaceuticals

Auckland, Newzealand
December 02-03, 2021

International Conference on Bio Pharmaceutics

Auckland, Newzealand
December 07-08, 2021

2nd International Conference on Biotechnology and Healthcare

Auckland, Newzealand
December 15-16, 2021

12th World Congress on Bioavailability and Bioequivalence

Bali, Indonesia
December 15-16, 2021

12th World Congress on Bioavailability and Bioequivalence

Prague, Czech Republic

Pharmacovigilance and Risk Management Conference Speakers

Recommended Sessions

Related Journals

Are you interested in